Our previous studies reported that berberine could reduce ischemia/reperfusion-induced myocardial apoptosis, improve mesenteric artery insulin sensitivity in diabetes [26], and reduce diabetic myocardial damage by inhibiting IGF-1R signaling [13]. This evidence concerns the gene INS and diabetes mellitus.